Detail akcie Cutera online

Business Summary: Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Company’s Cutera Core segment consists of the Company’s systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Company’s AviClear segment consists of the AviClear business. The Company’s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Cutera Inc revenues decreased 16% to $212.4M. Net loss increased 83% to $150.8M. Revenues reflect Products decrease of 17% to $189.8M, Service decrease of 4% to $22.6M. Higher net loss reflects Amortization of debt issuance costs increase of 65% to $2.2M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$4.39 to -$7.59.